Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
Plos One|May 29, 2026
Correction: A non-canonical function of zebrafish telomerase reverse transcriptase is required for developmental hematopoiesisShintaro Imamura, Junzo Uchiyama, Eriko Koshimizu, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 16, 2018
[Autologous peripheral blood stem cell transplantation for double-refractory myeloma with K-RAS and N-RAS mutations]Koji Jimbo, Kazuaki Yokoyama, Miho Ogawa, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 30, 2021
Association between thiamine decrease and neuropsychiatric symptoms in gastrointestinal and hematological cancer patients receiving chemotherapyYohei Iimura, Tomohiro Kurokawa, Shohei Andoh, et al.Plos One|October 11, 2008
A non-canonical function of zebrafish telomerase reverse transcriptase is required for developmental hematopoiesisShintaro Imamura, Junzo Uchiyama, Eriko Koshimizu, et al.Experimental Hematology|February 16, 2023
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myelomaRyosuke Kinoshita, Mariko Ishibashi, Hiroshi Handa, et al.International Journal of Hematology|September 2, 2025
Outcomes of patients aged 70 years or younger with aggressive ATL at core hospitals for ATL treatment in TokyoJunya Makiyama, Nobuhiro Ohno, Koji Jimbo, et al.Leukemia & Lymphoma|December 29, 2004
Clinical significance of peripheral blood erythroblastosis after hematopoietic stem cell transplantationSusumu Goyama, Yoshinobu Kanda, Yasuhito Nannya, et al.Journal of Experimental & Clinical Cancer Research : CR|March 24, 2021
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myelomaMitsuhito Hirano, Yoichi Imai, Yuta Kaito, et al.International Journal of Clinical Oncology|July 14, 2021
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapseHiroshi Yasui, Masayuki Kobayashi, Kota Sato, et al.Oncotarget|November 10, 2018
Clinical impact of serum soluble SLAMF7 in multiple myelomaMariko Ishibashi, Saori Soeda, Makoto Sasaki, et al.Pageof 9